Deepbridge Wins EISA Award
Deepbridge is pleased to announce that we have been awarded the ‘Spirit of EIS’ Award at the 2021 EISA Awards, which took place in The Cholmondeley Room at The House of Lords on the 7th October.
REQUEST E-APPLICATION FORM | 01244 746000 | Log in
Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.
Investments in unquoted companies carry high risks and investors could lose all funds invested. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. Investors are encouraged to take independent legal, tax and financial advice before considering an investment.
By clicking below, you confirm that you are an FCA authorised firm or individual and agree to be directed to our website, which is for FCA authorised firms and individuals only. Persons who do not meet this classification should leave this page.
If you are not a professional financial adviser, please contact the Deepbridge Investor Relations Team on 01244 746000 or by email at enquiries@deepbridgecapital.com.
Deepbridge is pleased to announce that we have been awarded the ‘Spirit of EIS’ Award at the 2021 EISA Awards, which took place in The Cholmondeley Room at The House of Lords on the 7th October.
Deepbridge Capital has now exceeded £200 million of funds deployed across is EIS and Estate Planning Service funds, with a current Net Asset Value (NAV) of over £250 million.
Deepbridge Capital has, to date, invested in 71 companies across the UK with Enterprise Investment Scheme (EIS) funding, a further 63 companies at the Seed EIS stage, with three profitable exits. Deepbridge Capital launched its first EIS Fund in the 2013/14 tax year specialising in providing venture capital to early-stage technology, life sciences and renewable energy companies.
One of Deepbridge Capital's Life Science EIS companies, Liverpool Chirochem Ltd., has announced the collaboration with Eurofins Discovery, a provider of products and services to the drug discovery industry.
One of Deepbridge Capital's Technology Growth EIS Companies, Hurricane Modular Commerce Limited, has been named 'Supplier of the Year' at this year’s Parcel & Post Technology International Awards.
Fund Her North has facilitated investment into six female led businesses worth over £4.2m in its first year, since it was established in October 2020.
One of Deepbridge Capitals Technology Growth EIS companies, AlgaeCytes Limited, was featured in Mitteldeutsche Zeitung (a regional daily newspaper for southern Saxony-Anhalt, Germany) highlighting AlgaeCytes project to build its first commercial production plant in Dessau, Germany.
One of Deepbridge's Technology Growth EIS Companies HeadBox, has finalised a £2 million fundraise led by Deepbridge Capital. This round has taken the total funding to £13.2 million.
Deepbridge Capital has deployed over £50 million of capital into UK life sciences companies.
The Deepbridge Life Sciences EIS was launched in 2017 as our first life sciences focused EIS fund, providing private investors with access to a portfolio of early-stage investee companies across the biopharmaceutical, biotechnology, medical technology and digital healthcare sectors.
Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.
What are the key risks?
1. You could lose all the money you invest
2. You are unlikely to be protected if something goes wrong
3. You won’t get your money back quickly
4. Don’t put all your eggs in one basket
5. The value of your investment can be reduced
If you are interested in learning more about how to protect yourself, visit the FCA’s website here. [https://www.fca.org.uk/investsmart]